Nauzene is a Oral Syrup in the Human Otc Drug category. It is labeled and distributed by Alva-amco Pharmacal Companies, Inc.. The primary component is Trisodium Citrate Dihydrate; Dextrose; Fructose.
| Product ID | 52389-172_b35b5e0f-9b2e-40ae-9db7-65f245e40844 |
| NDC | 52389-172 |
| Product Type | Human Otc Drug |
| Proprietary Name | Nauzene |
| Generic Name | Sodium Citrate |
| Dosage Form | Syrup |
| Route of Administration | ORAL |
| Marketing Start Date | 2000-02-15 |
| Marketing Category | OTC MONOGRAPH NOT FINAL / OTC MONOGRAPH NOT FINAL |
| Application Number | part357 |
| Labeler Name | Alva-Amco Pharmacal Companies, Inc. |
| Substance Name | TRISODIUM CITRATE DIHYDRATE; DEXTROSE; FRUCTOSE |
| Active Ingredient Strength | 1 g/15mL; g/15mL; g/15mL |
| NDC Exclude Flag | E |
| Listing Certified Through | 2018-12-31 |
| Marketing Start Date | 2000-02-15 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | OTC monograph not final |
| Application Number | part357 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2000-02-15 |
| Inactivation Date | 2020-01-31 |
| Ingredient | Strength |
|---|---|
| TRISODIUM CITRATE DIHYDRATE | .921 g/15mL |
| SPL SET ID: | 728376f5-6cab-404e-b519-f6c595291d6f |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 52389-172 | Nauzene | Sodium Citrate |
| 52389-242 | Nauzene | Sodium Citrate |
| 62646-798 | Anticoagulant Sodium Citrate | Sodium Citrate |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() NAUZENE 74469794 1909137 Live/Registered |
ALVA-AMCO PHARMACAL COS., INC. 1993-12-16 |